Vormatrogine not checked

Praxis Precision Medicines

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
2 in total · 2 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Focal Epilepsy, Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Main trialPhase 3
“A multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of vormatrigine in adults with focal seizures (POWER2)”In the company’s words, NCT07505004 on ClinicalTrials.gov

Other drugs for Focal Epilepsy

All 9 drugs for Focal Epilepsy

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Jan 2027 Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Phase 3Enrolling by invitation 31 May 2028 Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Vormatrogine

Following is part of Solo: you see every change to Vormatrogine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in